<!DOCTYPE html>
<html>
  <head>
    <title>Combined oral contraceptive</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/womens_health/">womens_health</a></li>
      <li><a href="/notes/womens_health/contraceptives/">contraceptives</a></li>
      <li class="active">Combined oral contraceptive</li>
  </ol>

  <div class="page-header">
 
    <h1>Combined oral contraceptive</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Combined oral contraceptive</strong></a>
          <div class="toc">
<ul>
<li><a href="#fully-funded">Fully funded:</a><ul>
<li><a href="#1st-generation">1st generation</a></li>
<li><a href="#2nd-generation">2nd generation</a></li>
<li><a href="#3rd-generation">3rd generation</a></li>
<li><a href="#vaginal-ring">Vaginal ring</a></li>
</ul>
</li>
<li><a href="#mechanism-of-action">Mechanism of action</a></li>
<li><a href="#efficacy">Efficacy</a></li>
<li><a href="#history-and-exam">History and exam</a><ul>
<li><a href="#ukmec-uk-medical-eligibility-criteria">UKMEC - UK Medical Eligibility Criteria</a><ul>
<li><a href="#migraine">Migraine</a></li>
<li><a href="#vte">VTE</a></li>
<li><a href="#smokers">Smokers</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#starting-pill">Starting pill</a></li>
<li><a href="#switching-pills">Switching pills</a></li>
<li><a href="#missed-pills">Missed pills</a><ul>
<li><a href="#one-pill-being-missed">One pill being missed:</a></li>
<li><a href="#two-or-more-pills-missed-6272h-since-last-pill-6248hrs-late">Two or more pills missed (>72h since last pill, >48hrs late):</a><ul>
<li><a href="#minimising-risk-of-pregnancy">Minimising risk of pregnancy</a><ul>
<li><a href="#first-week-1-7">First week: 1-7</a></li>
<li><a href="#second-week-8-14">Second week: 8-14</a></li>
<li><a href="#third-week-15-21">Third week: 15-21</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li><a href="#drug-interactions">Drug interactions</a><ul>
<li><a href="#antibiotics">Antibiotics:</a></li>
<li><a href="#enzyme-inducing-drugs">Enzyme inducing drugs:</a></li>
<li><a href="#lamotrigine">Lamotrigine:</a></li>
</ul>
</li>
<li><a href="#risks">Risks</a><ul>
<li><a href="#vte_1">VTE:</a></li>
<li><a href="#cardiovascular-disease-and-stroke">Cardiovascular disease and stroke:</a></li>
<li><a href="#breast-cancer">Breast cancer:</a></li>
<li><a href="#cervical-cancer">Cervical cancer</a></li>
</ul>
</li>
<li><a href="#benefits">Benefits</a><ul>
<li><a href="#mortality">Mortality</a></li>
<li><a href="#ovarian-and-endometrial-cancer">Ovarian and endometrial cancer</a></li>
<li><a href="#acne">Acne</a></li>
<li><a href="#bone-health">Bone health</a></li>
<li><a href="#colorectal-cancer">Colorectal cancer</a></li>
<li><a href="#dysmenorrhoea-and-heavy-menstrual-bleeding">Dysmenorrhoea and heavy menstrual bleeding</a></li>
<li><a href="#menopause">Menopause:</a></li>
</ul>
</li>
<li><a href="#side-effects">Side effects:</a><ul>
<li><a href="#unscheduled-bleeding">Unscheduled bleeding</a></li>
<li><a href="#mood-changes">Mood changes:</a></li>
<li><a href="#weight-gain">Weight gain:</a></li>
</ul>
</li>
<li><a href="#strategies">Strategies:</a><ul>
<li><a href="#acne_1">Acne</a></li>
<li><a href="#amenorrhoea">Amenorrhoea</a></li>
<li><a href="#breakthrough-bleeding">Breakthrough bleeding</a></li>
<li><a href="#breast-soreness">Breast soreness</a></li>
<li><a href="#depression-moodiness-irritability">depression, moodiness, irritability</a></li>
<li><a href="#headaceh-in-pill-free-week">Headaceh in pill-free week</a></li>
<li><a href="#menstrual-cramps">Menstrual cramps</a></li>
<li><a href="#nausea">Nausea</a></li>
<li><a href="#weight-gain_1">Weight gain</a></li>
</ul>
</li>
<li><a href="#quick-starting">Quick starting</a></li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <h3 id="fully-funded">Fully funded:</h3>
<h4 id="1st-generation">1st generation</h4>
<ul>
<li>
<p>norethisterone 500µg + ethinylestradiol 35µg</p>
<ul>
<li>
<p>Brevinor (no sugar)</p>
</li>
<li>
<p>Norimin</p>
</li>
</ul>
</li>
<li>
<p>norethisterone 1mg + ethinylestradiol 35µg</p>
<ul>
<li>Brevinor-1</li>
</ul>
</li>
</ul>
<h4 id="2nd-generation">2nd generation</h4>
<ul>
<li>
<p>Levonorgestrel 100 + ethinylestradiol 20</p>
<ul>
<li>
<p>Ava20</p>
</li>
<li>
<p>Microgynon</p>
</li>
</ul>
</li>
<li>
<p>Levonorgestrel 125µg + ethinylestradiol 50ug</p>
<ul>
<li>Microgynon 50</li>
</ul>
</li>
<li>
<p>Levonorgestrel 150µg + ethinylestradiol 50µg</p>
<ul>
<li>
<p>Ava 30</p>
</li>
<li>
<p>Levlen ED</p>
</li>
<li>
<p>Microgynon 30 (SA)</p>
</li>
<li>
<p>Monofeme</p>
</li>
<li>
<p>Nordette</p>
</li>
<li>
<p>Roxanne (SA)</p>
</li>
</ul>
</li>
</ul>
<h4 id="3rd-generation">3rd generation</h4>
<ul>
<li>
<p>cyproterone acetate 2mg + ethinylestradiol 35µg:</p>
<ul>
<li>
<p>Ginet</p>
<ul>
<li>
<p>use contraceptive (code = “O”)</p>
</li>
<li>
<p>can then use 6 months supply</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>drosgestrel 150µg + ethinylestradiol 20µg</p>
<ul>
<li>Mercilon (part)</li>
</ul>
</li>
<li>
<p>drosgestrel 150µg + ethinylestradiol 30µg</p>
<ul>
<li>Marvelon (part)</li>
</ul>
</li>
</ul>
<h4 id="vaginal-ring">Vaginal ring</h4>
<ul>
<li>
<p>Ethinylestradiol 15µg/24hrs + etonogestrel 120/24hrs</p>
<ul>
<li>
<p>NuvaRing</p>
<ul>
<li>
<p>can have 4 rings</p>
</li>
<li>
<p>keep at room temp</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="mechanism-of-action">Mechanism of action</h3>
<ul>
<li>
<p>inhibit ovulation: HPO axis</p>
<ul>
<li>decrease LH &amp; FSH via -ve feedback</li>
</ul>
</li>
<li>
<p>+ change cervical mucous &amp; endometrium</p>
</li>
<li>
<p>1st 7 pills inhibit ovulation</p>
</li>
<li>
<p>remaining 14 maintain ovulation</p>
</li>
<li>
<p>7 placebo -> withdrawal bleed</p>
<ul>
<li>endometrial shedding</li>
</ul>
</li>
<li>
<p>safe for extended use</p>
<ul>
<li>
<p>tricycling</p>
</li>
<li>
<p>7 pill free after 3rd packet</p>
</li>
</ul>
</li>
</ul>
<h3 id="efficacy">Efficacy</h3>
<ul>
<li>
<p>failure rate = 0.3% with perfect use</p>
</li>
<li>
<p>typical use = 9% failure rate</p>
</li>
<li>
<p>COC effective regardless of BMI</p>
</li>
<li>
<p>unscheduled bleeding less common with CHC than with progestogen-only</p>
</li>
<li>
<p>cycle control better with COC containing 30-35</p>
</li>
</ul>
<h3 id="history-and-exam">History and exam</h3>
<ul>
<li>
<p>assess medical eligibility</p>
</li>
<li>
<p>migraine</p>
</li>
<li>
<p>cardiovascular risk factors:</p>
<ul>
<li>
<p>smoking</p>
</li>
<li>
<p>obesity</p>
</li>
<li>
<p>HTN</p>
</li>
<li>
<p>thombophilia</p>
</li>
<li>
<p>VTE</p>
</li>
<li>
<p>dyslipidaemia</p>
</li>
</ul>
</li>
<li>
<p>BP, weight, BMI: for first prescription</p>
</li>
</ul>
<h4 id="ukmec-uk-medical-eligibility-criteria">UKMEC - UK Medical Eligibility Criteria</h4>
<ul>
<li>
<p>evidence based recommendations</p>
</li>
<li>
<p>from FSRH.org1</p>
</li>
<li>
<p>from BPAC2</p>
</li>
</ul>
<h5 id="migraine">Migraine</h5>
<ul>
<li>
<p>COC contraindicated in migraine with aura</p>
<ul>
<li>discontinued if develop migraine with aura</li>
</ul>
</li>
<li>
<p>if develop migraine without aura while on COC </p>
<ul>
<li>
<p>should be stopped</p>
</li>
<li>
<p>especially ≥35yo</p>
</li>
</ul>
</li>
<li>
<p>Pre-existing migraine without aura \&lt;35 not CI to COC</p>
</li>
</ul>
<h5 id="vte">VTE</h5>
<ul>
<li>
<p>higher risk of VTE</p>
</li>
<li>
<p>CI current/past history</p>
</li>
<li>
<p>avoid:</p>
<ul>
<li>
<p>obesity</p>
</li>
<li>
<p>smoking </p>
</li>
<li>
<p>fhx ≤45</p>
</li>
</ul>
</li>
</ul>
<h5 id="smokers">Smokers</h5>
<ul>
<li>heavy smokers ≥35yo not advised</li>
</ul>
<h3 id="starting-pill">Starting pill</h3>
<ul>
<li>
<p>conception most likely = Day of ovulation or preceeding 24hours</p>
</li>
<li>
<p>risk of pregnancy in 1st 3/7 very unlikely</p>
</li>
<li>
<p>started up to and including D5 without need for additional contraception</p>
</li>
<li>
<p>beyond D5 can start if reasonably certain <strong>not</strong> pregnant</p>
<blockquote>
<p>not pregnant:</p>
</blockquote>
</li>
</ul>
<blockquote>
<ul>
<li>
<p>no symptoms or signs pregnancy + any:</p>
</li>
<li>
<p>has not had intercourse since last menses</p>
<ul>
<li>
<p>using reliable method of contraception (reliably + correct)</p>
</li>
<li>
<p>within first 7 days of a normal menstrual period</p>
</li>
<li>
<p>within 4 weeks post-partum for non-lactating women</p>
</li>
<li>
<p>wihin first 7 days post-abortion or miscarriage</p>
</li>
<li>
<p>full/nearly fully breastfeeding, amenorhoeic, and less than 6/12 post partum</p>
</li>
</ul>
</li>
<li>
<p>pregnancy test adds weight but only if ≥3 weeks since last UPSI</p>
</li>
</ul>
</blockquote>
<ul>
<li>
<p>additional precautions for next 7 days</p>
</li>
<li>
<p>post partum and not breast feeding:</p>
<ul>
<li>start d21 if no VTE rxfx</li>
</ul>
</li>
</ul>
<blockquote>
<h3 id="quick-starting">Quick starting</h3>
<p>if pregnancy excluded/reasonably certain not pregnant</p>
<p>Extra contraception:</p>
<p>D 1-5: no</p>
<p>D ≥ 6 or after Progesterone only emergency contraceptive: 7d</p>
<p>After ulipristal EC: 14d</p>
</blockquote>
<h3 id="switching-pills">Switching pills</h3>
<ul>
<li>
<p>COC - COC:</p>
<ul>
<li>
<p>start on day after last active pill</p>
</li>
<li>
<p>no extra</p>
</li>
</ul>
</li>
<li>
<p>POP/LNG-IUS:</p>
<ul>
<li>
<p>started imediately</p>
</li>
<li>
<p>7 day rule</p>
</li>
</ul>
</li>
<li>
<p>implant/depot</p>
<ul>
<li>
<p>start any time up to when repeat injection/implant due</p>
</li>
<li>
<p>no extra</p>
</li>
<li>
<p>COC suppresses ovulation by time inhibition of 1st method worn off</p>
</li>
</ul>
</li>
</ul>
<h3 id="missed-pills">Missed pills</h3>
<ul>
<li>
<p>pill that is completely omitted</p>
<ul>
<li>>24 hours passed since pill was due(48hours since last pill)</li>
</ul>
</li>
<li>
<p>ovulation may occur as inhibitory effects on ovary reduced</p>
</li>
<li>
<p>7 consecutive pills prevents ovulation</p>
<ul>
<li>therefore if 7 taken: theoretically up to 7 can be missed without any effect on contracptive efficacy</li>
</ul>
</li>
<li>
<p>weeks 2/3 are unlikely to result in loss of efficacy</p>
</li>
<li>
<p>follicular activity resumes during pill free week</p>
</li>
</ul>
<h4 id="one-pill-being-missed">One pill being missed:</h4>
<ul>
<li>
<p>missed pill taken as soon as remembered</p>
</li>
<li>
<p>remaining pills continued at usual time</p>
</li>
<li>
<p>EC not usually required</p>
<ul>
<li>consider if pills have been missed earlier in the packet or in the last week of previous packet</li>
</ul>
</li>
</ul>
<h4 id="two-or-more-pills-missed-6272h-since-last-pill-6248hrs-late">Two or more pills missed (>72h since last pill, >48hrs late):</h4>
<ul>
<li>
<p>most recent missed pill should be taken ASAP</p>
</li>
<li>
<p>remianing pills ocntinued</p>
</li>
<li>
<p>7 day rule</p>
<ul>
<li>over cautious in 2/3 week</li>
</ul>
</li>
</ul>
<h5 id="minimising-risk-of-pregnancy">Minimising risk of pregnancy</h5>
<h6 id="first-week-1-7">First week: 1-7</h6>
<ul>
<li>
<p>EC should be considered if unprotected sex ocured in:</p>
<ul>
<li>
<p>pill-free interval or </p>
</li>
<li>
<p>in the first week of pill-taking</p>
</li>
</ul>
</li>
</ul>
<h6 id="second-week-8-14">Second week: 8-14</h6>
<ul>
<li>no indication for EC if pills in preceeding 7 days have been taken</li>
</ul>
<h6 id="third-week-15-21">Third week: 15-21</h6>
<ul>
<li><strong>omit the pills-free interval</strong></li>
</ul>
<h3 id="drug-interactions">Drug interactions</h3>
<h4 id="antibiotics">Antibiotics:</h4>
<ul>
<li>
<p>additional precautions are not required when using non-enzyme inducint abx</p>
</li>
<li>
<p>unless vomiting or diarrhoea</p>
</li>
<li>
<p>however: BPAC</p>
<ul>
<li>
<p>colonic bacterial disturbance may inhibit enterohepatic circulation of oestrogen (progestegen not affected)</p>
</li>
<li>
<p>evidence = weak</p>
</li>
<li>
<p><strong>short courses \&lt;3w</strong> use additional for 7d after abx stopped and 7 active pills</p>
</li>
<li>
<p>after 3w gut flora resistance means that safe</p>
</li>
</ul>
</li>
</ul>
<h4 id="enzyme-inducing-drugs">Enzyme inducing drugs:</h4>
<ul>
<li>
<p>increase the metabolism of oestrogens/progesterogens</p>
</li>
<li>
<p>reduce contraceptive efficacy</p>
</li>
<li>
<p>ideally switch to method that is unaffected </p>
</li>
<li>
<p>additional precautions </p>
</li>
<li>
<p>COC ≥ 30µg EE</p>
</li>
<li>
<p>consider omitting/shortening pill-free or ≥ 50µg for short term use</p>
</li>
<li>
<p><strong>use alternative method</strong></p>
</li>
</ul>
<h4 id="lamotrigine">Lamotrigine:</h4>
<ul>
<li>
<p>serum levels of lamotrigine are reduced by CHC</p>
</li>
<li>
<p>increased sideeffects on cessation of CHC</p>
</li>
<li>
<p>increase lamotrigine levels during pill-free week</p>
</li>
</ul>
<h3 id="risks">Risks</h3>
<h4 id="vte_1">VTE:</h4>
<blockquote>
<p>risks per 100 000</p>
<ul>
<li>
<p>Non contracetive and not pregnant:  5/year</p>
</li>
<li>
<p>COC (1st gen = norethsterone, 2nd gen = levonorgestrel): 15/year</p>
</li>
<li>
<p>COC (desogestrel, drospirenone, cypterone): 25/year</p>
</li>
<li>
<p>Pregnancy: 60/year</p>
</li>
<li>
<p>Immediate post-partum: 300-400</p>
</li>
</ul>
</blockquote>
<ul>
<li>
<p>4-5/10 000 women-years in those who do <strong>not</strong> use oral contraceptives</p>
</li>
<li>
<p>risk = twice that == 9-10/10 000 women-years</p>
</li>
<li>
<p>desogestrel, cyproterone > levonorgestrel, orethisterone</p>
</li>
<li>
<p>greatest in first few months of starting</p>
</li>
<li>
<p>returns to that of non-users wihin weeks of discontinuation</p>
</li>
<li>
<p>pregnancy = 29/10 000 women-years</p>
</li>
<li>
<p>immediate post partum = 300-400/10 000 women-years</p>
</li>
<li>
<p>family history = poor indicator</p>
<ul>
<li>first degree relative with VTE \&lt; 45 as UKMEC 3</li>
</ul>
</li>
</ul>
<h4 id="cardiovascular-disease-and-stroke">Cardiovascular disease and stroke:</h4>
<ul>
<li>
<p>women ≥35 who smoke \&lt;15 = UKMEC 3</p>
</li>
<li>
<p>women ≥35 who smoke >15 = UKMEC 4</p>
</li>
<li>
<p>≥ 1 year after giving up ≥ 35 then risk UKMEC 2</p>
</li>
<li>
<p>risk of stroke increased in COC with migraine compared to without migraine</p>
</li>
<li>
<p>migraine with aura</p>
<ul>
<li>COC increases risk of ischaemic stroke</li>
</ul>
</li>
<li>
<p>hypertension</p>
<ul>
<li>
<p>≥150mmHg sBP or ≥95mmHg dBP = UKMEC4</p>
</li>
<li>
<p>controlled = UKMEC3</p>
</li>
</ul>
</li>
<li>
<p>Obesity</p>
<ul>
<li>UKMEC3 for BMI ≥35</li>
</ul>
</li>
</ul>
<h4 id="breast-cancer">Breast cancer:</h4>
<ul>
<li>
<p>with family history:</p>
<ul>
<li>
<p>increased risk of breast cancer compared to women with no fhx</p>
</li>
<li>
<p>background risk increased</p>
<ul>
<li>not sufficiently extra with COC</li>
</ul>
</li>
<li>
<p>family history doens’t restrict use COC - UKMEC 1</p>
</li>
</ul>
</li>
<li>
<p>BRCA mutations</p>
<ul>
<li>
<p>conflicting evidence</p>
</li>
<li>
<p>currently UKMEC 3</p>
</li>
</ul>
</li>
<li>
<p>Current breast cancer</p>
<ul>
<li>represents unacceptable risk</li>
</ul>
</li>
<li>
<p>Past/no evidence of disease</p>
<ul>
<li>UKMEC 3</li>
</ul>
</li>
</ul>
<h4 id="cervical-cancer">Cervical cancer</h4>
<ul>
<li>
<p>risk increase with duration of COC use</p>
</li>
<li>
<p>no recommendations to change</p>
</li>
</ul>
<h3 id="benefits">Benefits</h3>
<h4 id="mortality">Mortality</h4>
<ul>
<li>
<p>12% reduction all cause mortality</p>
</li>
<li>
<p>no overal increased risk cancer</p>
</li>
</ul>
<h4 id="ovarian-and-endometrial-cancer">Ovarian and endometrial cancer</h4>
<ul>
<li>
<p>COC reduced risk of ovarian and endometrial cancer</p>
<ul>
<li>
<p>every 5yrs approx. 20% reduction in risk ovarian</p>
</li>
<li>
<p>50% endometrial</p>
</li>
</ul>
</li>
<li>
<p>continues for several decades after stopping</p>
</li>
</ul>
<h4 id="acne">Acne</h4>
<ul>
<li>
<p>effective reducing inflammatory and non-inflammatory acne</p>
</li>
<li>
<p>especially cyproterone acetate</p>
</li>
</ul>
<h4 id="bone-health">Bone health</h4>
<ul>
<li>no effect</li>
</ul>
<h4 id="colorectal-cancer">Colorectal cancer</h4>
<ul>
<li>reduction in risk</li>
</ul>
<h4 id="dysmenorrhoea-and-heavy-menstrual-bleeding">Dysmenorrhoea and heavy menstrual bleeding</h4>
<ul>
<li>
<p>limited evidence from RCT that COC can improve pain or reduce menstrual blood loss compared to other treatments</p>
</li>
<li>
<p>COC treat pain associated with endometriosis</p>
</li>
</ul>
<h4 id="menopause">Menopause:</h4>
<ul>
<li>COC may reduce menopausal symptoms</li>
</ul>
<h3 id="side-effects">Side effects:</h3>
<h4 id="unscheduled-bleeding">Unscheduled bleeding</h4>
<ul>
<li>
<p>20% of COC have irregular bleeding</p>
</li>
<li>
<p>usually settles with time</p>
</li>
<li>
<p>contine COC for 3/12 before considering changing</p>
</li>
<li>
<p>likely cuases:</p>
<ul>
<li>
<p>missed pills</p>
</li>
<li>
<p>STI</p>
</li>
<li>
<p>pregnancy</p>
</li>
<li>
<p>malabsorption (vomiting within 2 hours)</p>
</li>
</ul>
</li>
</ul>
<h4 id="mood-changes">Mood changes:</h4>
<ul>
<li>no evidence causes depression</li>
</ul>
<h4 id="weight-gain">Weight gain:</h4>
<ul>
<li>no causal association between COC and weight gain</li>
</ul>
<h3 id="strategies">Strategies:</h3>
<h4 id="acne_1">Acne</h4>
<ul>
<li>
<p>increase oestrogen</p>
</li>
<li>
<p>decrease progestogen</p>
</li>
<li>
<p>change to less adrogenic progestogen (Cypertone)</p>
</li>
</ul>
<blockquote>
<p>Ginet</p>
</blockquote>
<h4 id="amenorrhoea">Amenorrhoea</h4>
<ul>
<li>
<p>increase oestrogen</p>
</li>
<li>
<p>decrease progestogen</p>
</li>
</ul>
<blockquote>
<p>microgynon 50</p>
</blockquote>
<h4 id="breakthrough-bleeding">Breakthrough bleeding</h4>
<ul>
<li>
<p>early-mid cycle</p>
<ul>
<li>increase oestrogen</li>
</ul>
</li>
</ul>
<blockquote>
<p>microgynon 50</p>
</blockquote>
<ul>
<li>
<p>late cycle</p>
<ul>
<li>increase progestogen or change type</li>
</ul>
</li>
</ul>
<blockquote>
<p>Brevinor-1</p>
</blockquote>
<h4 id="breast-soreness">Breast soreness</h4>
<ul>
<li>
<p>decrease oestrogen</p>
</li>
<li>
<p>decrease progestogen</p>
</li>
</ul>
<blockquote>
<p>Ava 20</p>
</blockquote>
<h4 id="depression-moodiness-irritability">depression, moodiness, irritability</h4>
<ul>
<li>decrease progestogen</li>
</ul>
<blockquote>
<p>Ava 20, Microgynon 20, Loette</p>
</blockquote>
<h4 id="headaceh-in-pill-free-week">Headaceh in pill-free week</h4>
<ul>
<li>tri-cycle pills</li>
</ul>
<h4 id="menstrual-cramps">Menstrual cramps</h4>
<ul>
<li>
<p>increase progestogen</p>
</li>
<li>
<p>tricycle</p>
</li>
</ul>
<blockquote>
<p>Brevinor-1</p>
</blockquote>
<h4 id="nausea">Nausea</h4>
<ul>
<li>decrease oestrogen</li>
</ul>
<blockquote>
<p>Ava 20</p>
</blockquote>
<h4 id="weight-gain_1">Weight gain</h4>
<ul>
<li>
<p>decrease oestrogen</p>
</li>
<li>
<p>decrease progestogen</p>
</li>
</ul>
<blockquote>
<p>Ava 20</p>
</blockquote>
<p>1:  http://www.fsrh.org/pdfs/ukmecsummarysheets2009.pdf "UKMEC - FSRH"</p>
<p>2:  http://www.bpac.org.nz/BPJ/2008/April/contraceptive.aspx
end</p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
